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Endoleak after endovascular aneurysm repair:
Duplex ultrasound imaging is better than
computed tomography at determining the need
for intervention
Greg C. Schmieder, MD, Christopher L. Stout, MD, Gordon K. Stokes, MD, F. Noel Parent, MD, and
Jean M. Panneton, MD, Norfolk Va
Objective: Color duplex ultrasound (CDU) imaging is a noninvasive alternative to computed tomography (CT) for the
detection of endoleak. This study compared CT and CDU imaging in the detection of endoleaks requiring intervention
after endovascular aneurysm repair (EVAR).
Methods: All EVARs performed at our institution from 1996 to 2007 were retrospectively reviewed. CDU and CT scans
<3 months were paired and the presence of an endoleak and its type were recorded. Clinical follow-up was reviewed and
interventions for endoleak were recorded. Interventions were performed for type I, for type II with sac enlargement, and
for type III endoleaks. The first analysis of clinical test outcomes used the findings of CT scan as a gold standard and the
second used the findings at time of intervention as a gold standard.
Results: During the time period reviewed, 496 patients underwent EVAR, and 236 of these had CDU and CT follow-up
studies paired<3 months of each other. Mean follow-up was 17 months (range,<1-111 months). We reviewed 944 studies
or 472 pairs. Eighteen patients (7.6%) required intervention for 19 endoleaks: six type I, 11 type II, and two type III. Early
endoleak (<1 month) requiring reintervention was detected in 1 vs late endoleak (mean, 28 months; range, 0.6-88 months)
in 18. All type I and III endoleaks were treated with endovascular cuff or limb extension placement. Three type II endoleaks
were treated with open ligation, and coil or glue embolization was used in eight. CDU imaging detected endoleaks requiring
intervention in 89% of cases, whereas CT detected endoleak in 58% (P < .05). The ability to correctly identify the type of
endoleak as confirmed at time of intervention was 74% with CDU imaging vs 42% by CT (P < .05). CDU, for the detection
of endoleak requiring intervention, had a sensitivity of 90%, specificity of 81%, negative predictive value (NPV) of 99%, and
positive predictive value (PPV) of 16%, while CT had a sensitivity of 58%, specificity of 87%, NPV of 98%, and PPV of 15%.
Conclusions:CDU imaging has a high sensitivity in detecting endoleaks requiring intervention, is better at identifying the
type of endoleak, and is an excellent test for graft surveillance after endovascular aneurysm repair. Compared with CT
scan, CDU imaging in our experience is the preferred test on which to base an intervention for endoleak. (J Vasc Surg
2009;50:1012-8.)Endovascular aneurysm repair (EVAR) has become the
main treatment of abdominal aortic aneurysms (AAA) dur-
ing the last decade. Although EVAR has shown decreased
morbidity and mortality compared with open AAA repairs,
the procedure has also been associated with different rates
and types of postoperative complications such as en-
doleaks.1-3 These complications can result either in reinter-
vention or in the need for closer surveillance. Hence,
long-term surveillance after EVAR has become paramount
to identify these complications and allow for secondary
interventions to maintain an optimal outcome after EVAR.
A contrast-enhanced computed tomography (CT) scan
has been the gold standard for postoperative surveillance of
EVAR. CT surveillance, however, is associated with the
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1012cumulative risks of contrast nephrotoxicity, radiation expo-
sure, and cost.4 Recent studies have shown an increased risk
of radiation-induced cancer after repeated exposures from
CT scans.5-8 On the other hand, surveillance with color
duplex ultrasound (CDU) imaging does not have either of
these risks. Although CDU imaging has been used for
preoperative AAA surveillance, its role with EVAR surveil-
lance is still debated.9 There have been conflicting studies
on its efficacy compared with CT scan.10-12 The ultimate
success of a screening test is to accurately predict the disease
process and guide appropriate interventions.
We reviewed all articles evaluating CDU surveillance
for endografts using CT scan as a gold standard. We per-
formed a retrospective review of our experience with CDU
and CT surveillance to detect endoleaks and whether this
correctly correlated with the actual findings at the time of
reintervention after EVAR. We compared both imaging
studies to a commonmeasure, the endoleak detected at the
time of intervention.
PATIENTS AND METHODS
A retrospective review was performed on patients with
AAAs who underwent elective treatment with EVAR from
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with paired imaging studies (CDU and CT)3 months of
each other were included. The analysis excluded patients
with symptomatic or ruptured AAA and isolated iliac aneu-
rysms. Patient demographics, clinic notes, preoperative
CT/CDU scans, operative reports, types of EVAR devices,
CT and CDU surveillance studies were reviewed after
approval by the Institutional Review Board.
CDU or CT examinations within a week of each other
were scheduled at 1, 3, 6, and 12 months, and annually
thereafter. We adhered to our CDU imaging protocol
previously reported by Sato et al.12 After an overnight fast,
patients were placed supine and studied with a low fre-
quency (range, 2.5-5 MHz) curved array, phased array, or
mechanical sector, and pulsed Doppler scan transducer.
The endograft, proximal and distal fixation points, and the
AAA sac were imaged in B-mode. The size of the AAA sac
was measured.
The CDU scan was performed in sagittal and transverse
views to evaluate the AAA sac for the presence of flow
outside the graft. Perigraft leaks were identified when re-
producible, pulsatile color Doppler scan flow images were
present outside the graft and within the AAA sac. Focus was
directed at the superior and inferior stent attachment, the
anterior mid-AAA sac (inferior mesenteric artery), and the
posterior mid-AAA sac (lumbar arteries). CDU scan evi-
dence of an endoleak required the identification of perigraft
Doppler scan signals with color flow and was confirmed
with spectral analysis and mapping of blood flow pattern
(Fig).
All CDU examinations occurred in a peripheral vascu-
lar laboratory accredited by the Intersocietal Commission
for the Accreditation of Vascular Laboratories and were
performed by vascular technicians with RVTS certification
after being proctored by senior technicians. The results
were read by vascular surgeons.
CT scan surveillance was performed using a GE Light-
speed plus 16-slice scanner (GE Healthcare, Waukesha,
Wis) using 2.5-mm acquisition slice. Omnipaque 350 con-
trast (120 mL; GEHealthcare) was injected at a rate of 4 to
5 mL/s using SmartPrep software (GE Healthcare). The
arterial phase acquisition was obtained by an average delay
of 25 seconds after injection. The delayed phase was
obtained at 70 seconds after completion of first scan. CT
scan reconstruction used a 0.625-mm format.
Interpretation of CT scan results was performed by
radiology, whereas vascular surgery interpreted CDU re-
sults. Vascular surgeons made clinical decisions by review-
ing both imaging modalities and the patient’s clinical find-
ings. Endoleaks were categorized as type I, type II, type III
or indeterminate. The CDU examination was considered
inadequate if the endograft graft was poorly or incom-
pletely seen secondary to patient habitus or obscured by
bowel gas. In this study, only adequate CDU studies were
examined. Studies were adequate if they visualized (1) the
AAA residual sac, (2) the proximal and distal fixation
points, and (3) the endograft and bilateral limbs. An inter-nal review of CDU for EVAR surveillance revealed a 1% rate
of inadequate studies.
The types of reinterventions, findings at reintervention,
and the paired imaging studies obtained3 months before
reintervention were evaluated. The type of endoleak re-
ported at the time of intervention was compared with the
predicted type of endoleak by imaging studies. The type of
endoleak found at the time of intervention was determined
by angiography or open surgical findings. Early endoleaks
and reinterventions were defined by detection or interven-
tion 30 days of EVAR deployment. Late endoleaks and
reinterventions were defined by detection or intervention
after 30 days of EVAR deployment.
Commercially available and investigational devices
were used during the study period. They included 160
AneuRx (Medtronic, Santa Rosa, Calif), 55 Ancure/EVT
(Guidant, Indianapolis, Ind), 13 Zenith (Cook, Indianap-
olis, Ind), 5 Powerlink (Endologix, Irvine, Calif), 2 Ex-
cluder (W. L. Gore & Associates, Flagstaff, Ariz), and 1
Quantum (Cordis, New Brunswick, NJ).
Data were analyzed using XLStat software (Addinsoft
USA, New York, NY). Continuous data are expressed as
mean with standard deviation and were compared using the
t test. Noncontinuous data are expressed as percentages
and were compared by using the z test comparison for
proportions. P .05 was considered statistically significant.
CDU/CT surveillance analysis was performed in two seg-
ments. First, CDU/CTwere analyzed in a two-by-two grid
for sensitivity, specificity, negative predictive value (NPV),
and positive predictive value (PPV). CT scan was used as a
gold standard. The second analysis (reintervention anal-
ysis) used the type of endoleak detected at the time of
reintervention as the gold standard for both CDU imag-
ing and CT.
RESULTS
Surveillance analysis. From July 11, 1996, through
March 31, 2007, 496 consecutive patients underwent an
EVAR procedure. Paired CDU and CT imaging studies
were obtained in 236 patients, of which 202 (86%) were
men. The mean age at the time EVAR was 72 years (range,
51-90 years). The study population compromised 211
whites (89%), 20 African Americans (8%), 4 Asians (2%),
and 1 Hispanic.
The analysis reviewed 472 paired imaging studies or
944 studies. The mean interval between CDU and CT
scans was 18 days (range, 0-90 days), and 33% of paired
studies were performed 4 days of each other. A CT scan
was obtained before CDU scan 69% of the time (n 325),
a CDU study was obtained before the CT scan 15% of the
time (n 71), and both studies were obtained on the same
day 16% of the time (n  76). There were no statistically
significant differences in these intervals in patients with
endoleaks vs those without endoleaks, nor in patients re-
quiring an intervention vs those without an intervention.
The mean follow-up time was 17 months (ranged,1-111
months).
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detected by CT or CDU scan. There were 8 type I en-
doleaks, 123 type II endoleaks, 4 type III endoleaks, and 2
indeterminate endoleaks (one detected by CDU only and
the other detected by CT only). During the surveillance, 91
patients (39%) were found to have an endoleak, comprising
25 endoleaks 30 days (18%) compared with 112 late
endoleaks (82%). CDU imaging detected 110 endoleaks
compared with 75 by CT, which was significant (P  .01).
There was moderate agreement between the two tests for
detection of endoleak by association analysis (  0.42).
The CDU sensitivity, specificity, PPV, and NPV for
overall endoleak detection were 64%, 84%, 44%, and 93%
(Table I). CDU imaging showed a trend toward better
detection of type I endoleaks compared with CT scan
(CDU, 7 of 8 vs CT, 4 of 8; P  .10). CDU and CT
performed equally well for type III endoleak detection
(CDU, 3 of 4 vs CT, 4 of 4; P .29). The CDU sensitivity,
specificity, PPV, and NPV for type I endoleaks were 75%,
99%, 43%, respectively, and for type III endoleaks, 99% and
75%, 100%, 100%, and 99%. CDU performed better than
CT at detection of type II endoleaks (CDU, 99 of 123 vs
CT, 66 of 123; P .05). CDU sensitivity, specificity, PPV,
and NPV for type II endoleaks were 64%, 86%, 42%, and
94%, respectively.
Reintervention analysis. To better compare the clin-
ical utility of these two modalities, the endoleak confirmed
at time of reintervention was used as the gold standard to
compare CDU imaging and CT. Eighteen patients (7.6%)
required interventions for 19 endoleaks, comprising six
type I, 11 type II, and two type III. One early (1 month)
endoleak reintervention occurred vs 18 late (mean, 28
months; range, 0.6-88 months) endoleak reinterventions.
All type I and III endoleaks were treated with endovascular
cuff or limb extension placement. Type II endoleaks under-
went intervention if there was aneurysmal sac enlargement
or large aneurysmal sac with failure to regress. Three type II
endoleaks were treated with open ligation, whereas coil or
glue embolization was used in eight.
CDU detected an endoleak requiring intervention in
89% of cases, whereas CT detected endoleak in only 58%
(P  .05). The ability to correctly identify the type of
endoleak as confirmed at time of intervention was 74% with
Table I. Overall endoleak detection of color duplex
ultrasound vs computed tomography scana
Color duplex ultrasound
Positive Negative Totals
CT scan
Positive 48 27 75
Negative 62 335 397
Totals 110 362 472
CT, computed tomography.
aSensitivity, 64%; specificity, 84%; positive predictive value, 44%; negative
predictive value; 93%.CDU compared with 42% by CT (P  .05). CDU missedone type I and one type II endoleaks. CDU also incorrectly
detected type II endoleaks for one actual type I and two
type III endoleaks. CT scan missed two type I and six type
II endoleaks and incorrectly detected type II endoleaks for
one actual type I endoleak and two type III endoleaks. For
the detection of endoleak requiring intervention, CDU
imaging had a sensitivity of 90%, specificity of 81%, NPV of
99%, and PPV 16%, whereas CT had a sensitivity of 58%,
specificity of 87%, NPV of 98%, and PPV of 15% (Table II,
A and B).
DISCUSSION
The goal of surveillance or screening tests is to not miss
a diagnosis or complication; that is, have a high sensitivity
and NPV. The crux of this assessment lies in the chosen
gold standard. For AAA screening and surveillance, CDU
imaging has been the modality of choice.9 For EVAR
surveillance, a contrast CT scan as a comparison standard
has been an arbitrary choice. Studies comparing CDU with
CT scan for endoleak detection have produced mixed re-
sults. Sato et al12 and d’Audiffret et al13 both showed that
CDU is an excellent screening test for endoleaks, with
sensitivities of 97% and 96%, respectively. Elkouri et al,10
however, found poor results for CDU endoleak detection,
with a sensitivity of 25% and specificity of 89%.Most studies
comparing CDU with CT for endoleak detection, how-
ever, show modest sensitivities of 52% to 81% and good
NPV of 86% to 95%.14-18 This study also shows a modest
sensitivity of 64%, but an excellent NPV of 93%. Our results
almost mirror the meta-analysis results of Sun,19 which
showed an overall sensitivity, specificity, PPV, and NPV
value for endoleaks of 66%, 93%, 76%, and 90%, respec-
tively.
Although CDU sensitivity for overall endoleak detec-
tion appears adequate at best, the decrease in sensitivity
Table II. Overall endoleak detection at time of
reintervention for (A) color duplex ultrasound imaging
and (B) computed tomography scan
Intervention
TotalsYes No
A
CDUa
Positive 17 88 105
Negative 2 365 367
Totals 19 453 472
B
CT scanb
Positive 11 61 72
Negative 8 392 400
Totals 19 453 472
CDU, Color duplex ultrasonography; CT, computed tomography.
aSensitivity, 90%; specificity, 81%; positive predictive value, 16%; negative
predictive value, 99%.
bSensitivity, 58%; specificity, 87%; positive predictive value, 15%; negative
predictive value, 98%.occurred for type II endoleaks. CDU sensitivity for type I
JOURNAL OF VASCULAR SURGERY
November 20091016 Schmieder et aland III endoleak detection is excellent. AbuRahma et al18
found a similar pattern of worse outcomes for type II
endoleak detection vs type I. This decreased sensitivity can
be partially attributed to the statistics using CT scan as the
gold standard. If CDUwere used as the gold standard, then
CT would have a sensitivity of 44%. This study also showed
that CDU detected more type II endoleaks than CT by a
ratio of 1.5:1. Other studies have confirmed the ability of
CDU to better detect type II endoleaks than CT, with
ratios varying up to 2:1.11-13 Some studies have increased
detection of type II endoleaks with ultrasound con-
trast.20,21 Although contrast-enhanced CDU imaging may
aid in decreasing missed type II endoleaks, it increases the
amount of false-positive results, may be too sensitive, and
increases the cost of the study, the time of the study, and
the invasiveness of the study because patients require an
intravenous catheter. Finally, these studies have been in
small cohorts, and this experience has not been used more
broadly to truly assess its efficacy.
Overall, it appears that CDU provides an excellent
ability to detect type I and type III endoleaks, which are the
most worrisome endoleaks that require reintervention. Our
results also show that CT scans fail to show 50% of type I
endoleaks. We believe this results from confusion of distal
type I endoleaks for type II endoleaks with a static image
from a CT scan, whereas CDU can provide a more dynamic
picture illustrating the higher velocity flow associated with
type I endoleaks. On the other hand, several studies have
shown that both imaging modalities may miss type II
endoleaks. Hence, neither CT nor CDU imaging will de-
tect all type II endoleaks, nor do they need to detect all
endoleaks. Fortunately, the fate of type II endoleaks usually
follows a benign and often sporadic course. In addition,
this fate is intertwined with aneurysmal sac size, which may
ultimately serve as the main marker for EVAR surveillance.
Therefore, type II endoleak detection may be less impor-
tant than aneurysmal sac size.
The reintervention analysis is an attempt to compare
CDU with CT by using a shared gold standard of endoleak
confirmation at the time of reintervention. These results
clearly show that CDU imaging not only performs better
for endoleak detection than CT but also for identification
of the type of endoleak. This analysis, however, was per-
formed on a small subset of patients.
Which test is better? Neither test is or will be the perfect
screening test for EVAR surveillance. CDU imaging does
have limitations:
● It is operator-dependent, which may lead to disparate
findings between the different technicians.
● Suboptimal examinations due to body habitus or
bowel gas can compromise results. An internal review
of our CDU examinations during 1 year showed about
1% of studies were inadequate; however, this will vary
according to experience and patient population.
● Availability and time commitment restricts its broader
use; whereas CT scanners are ubiquitous and fast.● The ability of CDU to detect endograft migration is
currently unknown.
The limitations of CDU must be weighed with its
benefits. CDU offers no exposure to radiation, intravenous
contrast, and cheaper cost. On the other hand, CT scan
surveillance is more expensive and exposes patients to cu-
mulative risks of radiation and intravenous contrast. Recent
studies have raised awareness of the increased risk of cancer
after repeated exposures from CT scans.5-8 We have ob-
tained both CT scans and CDU imaging for EVAR surveil-
lance for several years. This provided a way to validate the
use of CDU.Over time this practice has evolved, with some
patients getting only CT scan, others CDU only, and still
others obtaining both.
Our study has several limitations. First, its retrospective
design contributed to incomplete data collection for some
preprocedural and postprocedural variables. A retrospec-
tive study can also introduce selection bias into patient
subsets. Our use of CDU, however, has been extensive and
has never been used selectively.
Second, there was an average of 18 days between the
CDU and CT scans. Although this time frame between
tests is relatively small, the behavior of endoleaks, recurring
and sealing, can be variable. This could lead to overestima-
tion or underestimation of endoleak detection by each
modality. Ideally, all scans would be perfectly paired each
day and every patient would follow our protocol. In clinical
practice, however, scheduling conflicts arise that limit the
ability to obtain both imaging studies in the same day. This
is retrospective study in which own surveillance protocol
was followed as best as possible.
Third, a wide variety of endografts were used during
the study. The variability of performance between the
different endografts may have confounded the outcomes.
This, however, reflects a true clinical practice. And the
ability of CDU imaging to monitor a variety of endografts
despite their different characteristics reaffirms its utility in
EVAR surveillance.
CONCLUSION
Duplex ultrasound imaging has a high sensitivity and
negative predictive value in detecting endoleaks requiring
intervention, is better at identifying the type of endoleak,
and is an excellent test for graft surveillance after endovas-
cular aneurysm repair. Compared with CT scan, our expe-
rience shows DU is the preferred test on which to base an
intervention for endoleak.
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Britt Tonnessen, MD (New Orleans, La). Thank you for an
excellent presentation on a topic of great interest to us all. In prior
publications, the group from Norfolk has championed the use of
Duplex ultrasound for the identification of endoleaks. Still, sensi-
tivity of endoleak detection, measured up against CT, ranges from
12% to 97% in the literature. The most obvious rationale for this
discrepancy is the variability among vascular laboratories and lack
of a standardized protocol, as the authors emphasize.
In this robust retrospective study, the authors identified more
endoleaks on US than on CT-particularly type II endoleaks. The
crux of this manuscript is in the authors’ contention that US is, in
their hands, more frequently able to identify those patients who
require a secondary procedure for their endoleak. They found a
sensitivity of 90% for US versus 58% for CT. Just so that we do not
lose total confidence in CT, a negative CT did successfully rule out
endoleak requiring intervention 98% of the time.
One shortcoming of these data is that the examinations were
not performed concurrently. Potentially, endoleaks may have re-
solved or appeared during the mean of 18 days between paired the
studies, introducing the possibility of a type I statistical error.
Skepticism aside, many of us have already adopted Duplex
ultrasound as part of our post-EVAR surveillance. Lack of a stan-
dardized regimen incorporating US has likely led to disparate
practices. At this meeting last year, data was presented that showed
that the absence of endoleak on the 1 and 12 month CT predictsmore “relaxed” regimen of CT follow-up, incorporating Duplex,
may be appropriate in this setting. Such algorithms need to be
prospectively validated and standardized.
I have the following questions for the authors:
1. What is the current surveillance algorithm in Norfolk? Given
the variability in ultrasound quality, do the authors believe that
this algorithm should and can be widely adopted?
2. Migration is one post-EVARcomplication that is time-dependent,
often occurring late in the follow-up.Migration is best detected
prior to the development of a type I endoleak. Particularly with
devices reported to have high migration rates, how do you
intend to follow these patients for migration?
3. If we assume that many of these endoleaks caught on US but
not on CT were “low-flow” and not false positives, how did
the authors decide when a type II endoleak was “clinically
significant”? In other words, what was your threshold for
intervention?
Gregory C. Schmieder, MD. Thank you for your questions.
The first question is about our surveillance protocol. We recently
adopted a protocol of duplex ultrasound at six months, twelve
months, eighteen and twenty-four months; no routine CT scans. If
there are any questions about an endoleak or we are concerned
secondary to sac enlargement or some other finding, then a CT
scan will be obtained. We use CT scans in a more isolated and
directed approach. In regards to migration, this is one of the weak
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however, the development of a Type 1 endoleak is the most
concerning outcome from migration. As we have demonstrated,
you can clearly detect Type 1 endoleaks very well with duplex color
ultrasound. Also, we are currently looking at measurements of the
distance from the renal artery to the stent grafts with duplex to see
if we can truly get a good measurement using duplex ultrasounddetermine when patients get reinterventions for Type 2 endoleaks
which as you mentioned were detected more with ultrasound
compared to CT scan. Most of that decision is based on clinical
variables, such as sac size enlargement. Is there an absolute defin-
itive number that we use at our institution? No. Some of it is
surgeon-specific. Also, another indication for intervention is a
persistent endoleak without sac regression in a large aneurysm,and that is a current ongoing study. The third question is how we which has been shown in studies to have more adverse outcomes.
